1961

COM:ALTEOGEN

Alteogen

  • Stock

Last Close

346.50K

22/11 06:30

Market Cap

14.32T

Beta: -

Volume Today

4.65M

Avg: -

ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars. The company develops ALT-P1, a long-acting human growth hormone that is in the Phase IIa clinical trial; and ALT-Q2, a long-acting active form of coagulation factor VII for the treatment of hemophilia based on its NexP technology. It is als...Show More

peer of

competitor of